Browsing HMS Scholarly Articles by Harvard-affiliated Author "Dr Daniel Robert Kuritzkes"

DSpace/Manakin Repository

DASH Home
Harvard Medical School
HMS Scholarly Articles
Browsing HMS Scholarly Articles by Harvard-affiliated Author

Browsing HMS Scholarly Articles by Harvard-affiliated Author "Dr Daniel Robert Kuritzkes"

Now showing items 1-12 of 12

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 \(gag\) Vaccine Trial

Brumme, Chanson J.; Lederman, Michael M.; Brumme, Zabrina L.; Wang, Hongying; Carrington, Mary; Medvik, Kathleen; Schooley, Robert T. et al. (PLoS ONE, 2012) Link to Published Version
Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa

Murphy, Richard A.; Marconi, Vincent C.; Gandhi, Rajesh Tim; Kuritzkes, Daniel Robert; Sunpath, Henry (PLoS ONE, 2012) Link to Published Version
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Bennett, Diane E.; Camacho, Ricardo J.; Otelea, Dan; Fleury, Hervé; Kiuchi, Mark; Heneine, Walid; Kantor, Rami et al. (PLoS ONE, 2009) Link to Published Version
Episomal Viral cDNAs Identify a Reservoir That Fuels Viral Rebound after Treatment Interruption and That Contributes to Treatment Failure

Sharkey, Mark; Babic, Dunja Z.; Greenough, Thomas; Gulick, Roy; Stevenson, Mario; Cullen, Bryan R.; Kuritzkes, Daniel Robert (PLoS Pathogens, 2011) Link to Published Version
Evolution of resistance in paediatric patients with failure on antiretroviral therapy

Orrell, C; Levison, J; Ciaranello, A; Bekker, L; Kuritzkes, D; Freedberg, Kenneth Alan; Wood, R (Journal of the International AIDS Society, 2012) Link to Published Version
Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load <48 Copies/mL

Henrich, Timothy Jensen; Wood, Brian R.; Kuritzkes, Daniel Robert (PLoS ONE, 2012) Link to Published Version
Monitoring Processed, Mature Human Immunodeficiency Virus Type 1 Particles Immediately Following Treatment with a Protease Inhibitor-containing Treatment Regimen

Baird, Heather A; Marozsan, Andre J; Lederman, Michael M; Landay, Alan; Mildvan, Donna; Kessler, Harold A; Arts, Eric J et al. (AIDS Research and Therapy, 2005) Link to Published Version
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo

Korber, Bette; Russ, Carsten; Lo, Chien-Chi; Leitner, Thomas; Gaschen, Brian; Theiler, James; Paredes, Roger et al. (PLoS ONE, 2009) Link to Published Version
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection

Graham, Barney S.; Stocker, Vicki; Maenza, Janine; Markowitz, Martin; Little, Susan; Collier, Ann C.; Nabel, Gary et al. (PLoS ONE, 2010) Link to Published Version
Simple filter microchip for rapid separation of plasma and viruses from whole blood

Wang, Shuqi; Sarenac, Dusan; Chen, Michael; Huang, Shih-Han; Giguel, Francoise F; Kuritzkes, Daniel Robert; Demirci, Utkan (International Journal of Nanomedicine, 2012) Link to Published Version
Treatment-Mediated Alterations in HIV Fitness Preserve CD4+ T Cell Counts but Have Minimal Effects on Viral Load

Vaidya, Naveen K.; Rong, Libin; Marconi, Vincent C.; Deeks, Steven G.; Perelson, Alan S.; Kuritzkes, Daniel Robert (PLoS Computational Biology, 2010) Link to Published Version
Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa

Orrell, Catherine; Gallien, Sébastien; Fu, Naishin; Wood, Robin; Levison, Julie H.; Kuritzkes, Daniel Robert; Losina, Elena et al. (PLoS ONE, 2012) Link to Published Version

Now showing items 1-12 of 12

Advanced Search

All of DASH
This Collection